Sign in to baba News

The Desk, the news read to you every hour, is part of News Plus.

or use an email code

Keep the whole picture

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Unlimited follows
  • Alerts for what you follow (in the app)
  • Story alerts (in the app)
  • Hide read stories
  • The daily brief by email
  • Headlines side by side
  • Who reported first
  • The whole archive
  • Your reading diet
  • Duki without the daily limit
  • The Desk: the news, spoken every hour
  • Catch Me Up, and what changed since you read it
  • The Live Terminal

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Sign in to baba News

One account across the web, iPhone and Android — your subscription follows it.

or use an email code

Welcome — one more step

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Unlimited follows
  • Alerts for what you follow (in the app)
  • Story alerts (in the app)
  • Hide read stories
  • The daily brief by email
  • Headlines side by side
  • Who reported first
  • The whole archive
  • Your reading diet
  • Duki without the daily limit
  • The Desk: the news, spoken every hour
  • Catch Me Up, and what changed since you read it
  • The Live Terminal

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Search stories

Type at least two characters. Results come from every newsroom baba reads.

↑↓ to move · ↵ to open · esc to close

Sign in to baba News

Sign in to keep asking. News Plus removes the daily limit.

or use an email code

Keep the whole picture

News Plus opens the cross-newsroom layer — who covered a story, who didn’t, and how each one worded it.

  • Unlimited follows
  • Alerts for what you follow (in the app)
  • Story alerts (in the app)
  • Hide read stories
  • The daily brief by email
  • Headlines side by side
  • Who reported first
  • The whole archive
  • Your reading diet
  • Duki without the daily limit
  • The Desk: the news, spoken every hour
  • Catch Me Up, and what changed since you read it
  • The Live Terminal

Eligible new subscribers get 7 days free, then $34.99 each year. Renews automatically until cancelled. Cancel any time in your account. Subscription terms.

Your subscription also unlocks the app.

Security13:45 · 1h ago

Israeli Firm Matriceal Targets US Military Market With Neural Implant

By מערכת ice
Translated & summarized from Ice by baba
The story · English

Israeli biotech company Matriceal is seeking to enter the U.S. military medical market with its innovative neural implant technology designed for nerve tissue regeneration. The company participated in the Defense TechConnect conference, a key event connecting technology firms with U.S. government, defense, research, and medical entities.

Matriceal was represented at the conference by Professor Alon Glazberg, former chief medical officer of the IDF and now a medical advisor to the company, and Dr. Tamar Harel, its VP of Research and Development. The company stated that its participation aimed to establish long-term relationships with organizations involved in developing and implementing medical technologies for trauma and war casualties.

The conference attendees included representatives from the U.S. Department of Defense, federal agencies, investors, and universities. Matriceal's technology involves creating a personalized, engineered neural implant using the patient's own cells, with a primary focus on treating traumatic spinal cord injuries to facilitate nerve tissue repair.

Dr. Harel described the technology as being in development, with the company preparing for its clinical phase. She emphasized that connecting with leading U.S. research and medical bodies is crucial for this development process. Professor Glazberg highlighted the significant need for new solutions for complex injuries, drawing on experience from Israeli military medicine, and suggested that combining Israeli regenerative medicine innovation with global military medical capabilities could open new treatment avenues for wounded soldiers.

Dr. Alon Sinai, Matriceal's founder and president, stated the company's goal is not just to showcase its technology but to build lasting relationships with entities that can help advance it from research to clinical application and patient treatment. This initiative represents a strategic move by Matriceal to expand its international operations, with a particular focus on the United States.

Read the original at Ice

Ask About This Article

Duki reads it, and every newsroom on the same story, then answers with sources.

Open the live terminal